An investigation for investors in STAAR Surgical Company was announced concerning potential breaches of fiduciary duties by certain directors of STAAR Surgical Company.
Investors who are current long term investors in STAAR Surgical Company (NASDAQ:STAA shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm for current long term investors in NASDAQ:STAA stocks follows a lawsuit filed against STAAR Surgical Company over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:STAA stocks, concerns whether certain STAAR Surgical officers and directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that defendants made certain false and/or misleading statements and/or failed to disclose that STAAR Surgical Company’s Monrovia Facility lacked adequate methodologies and facilities for the manufacture, packing, storage and installation of the Company’s implantable lenses, that STAAR Surgical Company’s Monrovia Facility lacked adequate procedures for documenting complaints, sterility testing, and maintaining required records, and that as a result of the foregoing, the Monrovia Facility was not in conformity with current good manufacturing practice requirements at all relevant times.
On July 1, 2014, the U.S. Food and Drug Administration (“FDA”) released a copy of a warning letter that it issued STAAR Surgical Company on May 21, 2014 concerning an inspection of STAAR Surgical Company’s Monrovia Facility which took place from February 10, 2014 to March 21, 2014. The FDA letter noted several regulatory violations at the facility and stated that, among other things, “the methods used in, or the facilities or controls used for” manufacture, packing, storage or installation of STAAR Surgical Company’s implantable lenses are “not in conformity with the current good manufacturing practice requirements.”
Those who purchased shares of STAAR Surgical Company (NASDAQ:STAA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego